- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07375459
Community-based Mobile-assisted Brief Intervention for Smoking Cessation
April 8, 2026 updated by: LUK Tzu Tsun, National University of Singapore
Mobile-assisted Brief Intervention for Smoking Cessation in Community-based Setting: a Pilot Randomised Controlled Trial
The goal of this pilot trial is to evaluate the feasibility of a mobile-assisted brief intervention for smoking cessation in community-based individuals in Singapore. Specific aims include:
- To assess how many eligible individuals accept the invitation to participate in the trial
- To assess the retention of the participants through 6 months after treatment initiation
- To assess the acceptability of the intervention in terms of participants' engagement and ratings
- To examine the intervention effect on abstinence outcomes
Participants will be randomly assigned to either the intervention group or control group and followed for 6 months from randomisation.
Study Overview
Status
Recruiting
Conditions
Study Type
Interventional
Enrollment (Estimated)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Tzu Tsun Luk, PhD, RN
- Phone Number: 65-66015938
- Email: luktt@nus.edu.sg
Study Contact Backup
- Name: Joey TW Tyoh, BSc, RN
- Email: joey.tyoh@nus.edu.sg
Study Locations
-
-
-
Singapore, Singapore
- Recruiting
- National University of Singapore
-
Contact:
- Tzu Tsun Luk, PhD, RN
- Phone Number: 65-66015938
- Email: luktt@nus.edu.sg
-
Contact:
- Joey TW Tyoh, BSc, RN
- Email: joey.tyoh@nus.edu.sg
-
Principal Investigator:
- Tzu Tsun Luk, PhD, RN
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Aged 21 to 80 years
- Smoked at least one cigarette daily
- Able to communicate and read in English or Chinese
- Own a smartphone with WhatsApp installed
Exclusion Criteria:
- Exposed to any smoking cessation treatment in the past 3 months
- Pregnant women
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Mobile-assisted brief intervention
|
Participants will receive brief cessation advice following the AWARD (ask, warn, advise, refer, do-it-again) model and a 24-page self-help booklet.
Research personnel will assist the participant in signing up for the I Quit Programme to receive additional cessation support, unless they decline
Participants will receive personalised chat-based support delivered by a live counsellor for 3 months via WhatsApp.
The message will incorporate behaviour change techniques for smoking cessation and mindfulness principles to strengthen participants' capacity to quit smoking.
|
|
Active Comparator: Brief advice
|
Participants will receive brief cessation advice following the AWARD (ask, warn, advise, refer, do-it-again) model and a 24-page self-help booklet.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Retention rate
Time Frame: 6 months
|
Number of participants completed the follow-up divided by the number of participants
|
6 months
|
|
Recruitment rate
Time Frame: 6 months
|
Number of participants divided by the number of eligible subjects
|
6 months
|
|
Biochemically validated smoking abstinence rate
Time Frame: 6 months
|
Defined as an exhaled carbon monoxide level of <5 parts per million or a negative salivary cotinine test (cut off 30ng/mL)
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Self-reported 7-day point-prevalence smoking abstinence rate
Time Frame: 3 months
|
Being completely smoke-free in the past 7 days
|
3 months
|
|
Self-reported 7-day point-prevalence smoking abstinence rate
Time Frame: 6 months
|
Being completely smoke-free in the past 7 days
|
6 months
|
|
Self-reported smoking reduction rate
Time Frame: 3 months
|
Smoking reduction by at least half of the baseline daily number of cigarettes in individuals who continue to smoke
|
3 months
|
|
Self-reported smoking reduction rate
Time Frame: 6 months
|
Smoking reduction by at least half of the baseline daily number of cigarettes in individuals who continue to smoke
|
6 months
|
|
Self-reported quit attempt rate
Time Frame: 3 months
|
Serious quit attempt that lasted 24 hours or longer
|
3 months
|
|
Self-reported quit attempt rate
Time Frame: 6 months
|
Serious quit attempt that lasted 24 hours or longer
|
6 months
|
|
Smoking cessation service use rate
Time Frame: 3 months
|
Use of any smoking cessation service during the follow-up period
|
3 months
|
|
Smoking cessation service use rate
Time Frame: 6 months
|
Use of any smoking cessation service during the follow-up period
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Tzu Tsun Luk, PhD, RN, National University of Singapore
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 4, 2026
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
March 31, 2027
Study Registration Dates
First Submitted
January 22, 2026
First Submitted That Met QC Criteria
January 22, 2026
First Posted (Actual)
January 29, 2026
Study Record Updates
Last Update Posted (Actual)
April 9, 2026
Last Update Submitted That Met QC Criteria
April 8, 2026
Last Verified
April 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NUS-IRB-2025-690
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Smoking &Amp; Tobacco Cessation
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedSmoking &Amp; Tobacco CessationUnited States
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI); Oregon Health and Science University; Kaiser... and other collaboratorsActive, not recruitingTobacco-Related Carcinoma | Smoking &Amp; Tobacco CessationUnited States
-
Claremont Graduate UniversityNational Cancer Institute (NCI)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, CigaretteUnited States
-
Mayo ClinicNational Institute on Drug Abuse (NIDA)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, Tobacco | Smoking, CigaretteUnited States
-
University of MiamiFlorida Department of HealthRecruitingSmoking Cessation | Tobacco Smoking | Tobacco Use CessationUnited States
-
Nabi BiopharmaceuticalsNational Institute on Drug Abuse (NIDA)CompletedSmoking | Smoking Cessation | Tobacco CessationUnited States
-
University of ArizonaNational Center for Complementary and Integrative Health (NCCIH); West Virginia...CompletedSmoking Cessation | Tobacco Use | Tobacco Smoking | Smoking, Tobacco | Guided ImageryUnited States
-
Heidelberg UniversityPfizerTerminatedSmoking | Smoking Cessation | Tobacco Use CessationGermany
-
University of OklahomaEnrolling by invitationTobacco Cessation | Tobacco Use | Tobacco Smoking | Smoking Cessation Financial Incentives | Socioeconomic Status | Contingency Management | PregnancyUnited States
-
Roswell Park Cancer InstituteCompletedTobacco Use | Tobacco Smoking | Cigarette Smoking | Smokeless Tobacco CessationUnited States
Clinical Trials on Brief cessation advice + self-help booklet
-
The University of Hong KongNot yet recruiting
-
Beijing Normal UniversityNot yet recruitingSmoking Cessation | Mobile HealthChina
-
Beijing Normal UniversityRecruiting
-
The University of Hong KongQueen Elizabeth Hospital, Hong Kong; Queen Mary Hospital, Hong Kong; Kwong Wah... and other collaboratorsRecruitingSmoking Cessation | Mobile Health | Post-dischargeChina
-
The University of Hong KongHong Kong Council on Smoking and HealthCompletedSmoking CessationHong Kong
-
The University of Hong KongActive, not recruiting
-
The University of Hong KongHong Kong Council on Smoking and HealthCompleted
-
The University of Hong KongHong Kong Council on Smoking and HealthRecruiting
-
The University of Hong KongRecruitingThe "Quit-for-Kids" Project: to Increase Abstinence and Protect Children From Tobacco Smoke ExposureSmoking Cessation | Second Hand Tobacco SmokeChina
-
The University of Hong KongHong Kong Council on Smoking and HealthActive, not recruiting